BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21757581)

  • 1. The role of Vldlr in intraretinal angiogenesis in mice.
    Xia CH; Lu E; Liu H; Du X; Beutler B; Gong X
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6572-9. PubMed ID: 21757581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model's retinal angiomatous proliferation.
    Hu W; Jiang A; Liang J; Meng H; Chang B; Gao H; Qiao X
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):407-15. PubMed ID: 18172119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of LRP5 in VLDLR knockout mice inhibits retinal neovascularization.
    Xia CH; Lu E; Zeng J; Gong X
    PLoS One; 2013; 8(9):e75186. PubMed ID: 24058663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse model of subretinal neovascularization with choroidal anastomosis.
    Heckenlively JR; Hawes NL; Friedlander M; Nusinowitz S; Hurd R; Davisson M; Chang B
    Retina; 2003 Aug; 23(4):518-22. PubMed ID: 12972764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe retinal degeneration caused by a novel rhodopsin mutation.
    Liu H; Wang M; Xia CH; Du X; Flannery JG; Ridge KD; Beutler B; Gong X
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1059-65. PubMed ID: 19741247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of VLDL receptor activates retinal vascular endothelial cells and promotes angiogenesis.
    Jiang A; Hu W; Meng H; Gao H; Qiao X
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):844-50. PubMed ID: 18936153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical alterations in the retinas of very low-density lipoprotein receptor knockout mice: an animal model of retinal angiomatous proliferation.
    Li C; Huang Z; Kingsley R; Zhou X; Li F; Parke DW; Cao W
    Arch Ophthalmol; 2007 Jun; 125(6):795-803. PubMed ID: 17562991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice.
    Hua J; Guerin KI; Chen J; Michán S; Stahl A; Krah NM; Seaward MR; Dennison RJ; Juan AM; Hatton CJ; Sapieha P; Sinclair DA; Smith LE
    Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2809-16. PubMed ID: 21282584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal neovascularization induced by mutant
    Yan WM; Long P; Chen MZ; Wei DY; Wang JC; Zhang ZM; Zhang L; Chen T
    Int J Ophthalmol; 2021; 14(7):990-997. PubMed ID: 34282382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress.
    Dorrell MI; Aguilar E; Jacobson R; Yanes O; Gariano R; Heckenlively J; Banin E; Ramirez GA; Gasmi M; Bird A; Siuzdak G; Friedlander M
    J Clin Invest; 2009 Mar; 119(3):611-23. PubMed ID: 19188685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurite Mistargeting and Inverse Order of Intraretinal Vascular Plexus Formation Precede Subretinal Vascularization in Vldlr Mutant Mice.
    Johnson V; Xiang M; Chen Z; Junge HJ
    PLoS One; 2015; 10(7):e0132013. PubMed ID: 26177550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photoreceptor degeneration and retinal inflammation induced by very low-density lipoprotein receptor deficiency.
    Chen Y; Hu Y; Moiseyev G; Zhou KK; Chen D; Ma JX
    Microvasc Res; 2009 Jun; 78(1):119-27. PubMed ID: 19281829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous Posterior Segment Vascular Disease Phenotype of a Mouse Model, rnv3, Is Dependent on the Crb1rd8 Allele.
    Chang B; FitzMaurice B; Wang J; Low BE; Wiles MV; Nishina PM
    Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):5127-5139. PubMed ID: 30372741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldlr knockout mouse.
    Zhou X; Wong LL; Karakoti AS; Seal S; McGinnis JF
    PLoS One; 2011 Feb; 6(2):e16733. PubMed ID: 21364932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARα-Dependent Effects of Palmitoylethanolamide Against Retinal Neovascularization and Fibrosis.
    Ye S; Chen Q; Jiang N; Liang X; Li J; Zong R; Huang C; Qiu Y; Ma JX; Liu Z
    Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):15. PubMed ID: 32298438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldlr null mice.
    Kyosseva SV; Chen L; Seal S; McGinnis JF
    Exp Eye Res; 2013 Nov; 116():63-74. PubMed ID: 23978600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization.
    Wang Z; Cheng R; Lee K; Tyagi P; Ding L; Kompella UB; Chen J; Xu X; Ma JX
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):855-64. PubMed ID: 25657312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration.
    Qiu F; Matlock G; Chen Q; Zhou K; Du Y; Wang X; Ma JX
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5065-5075. PubMed ID: 28980001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monogenic dominant mutation in Rom1 generated by N-ethyl-N-nitrosourea mutagenesis causes retinal degeneration in mice.
    Sato H; Suzuki T; Ikeda K; Masuya H; Sezutsu H; Kaneda H; Kobayashi K; Miura I; Kurihara Y; Yokokura S; Nishida K; Tamai M; Gondo Y; Noda T; Wakana S
    Mol Vis; 2010 Mar; 16():378-91. PubMed ID: 20300562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ENU-induced mutation in Rs1h causes disruption of retinal structure and function.
    Jablonski MM; Dalke C; Wang X; Lu L; Manly KF; Pretsch W; Favor J; Pardue MT; Rinchik EM; Williams RW; Goldowitz D; Graw J
    Mol Vis; 2005 Jul; 11():569-81. PubMed ID: 16088326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.